Discovery of new biomarkers and therapeutic targets
We have identified methylation signatures associated with disease and aging, revealing biomarkers and new therapeutic targets to accelerate research in these areas.
R&D Services
Epigenomic Intelligence for Your Company
Turn research into a competitive advantage with EpiBio, an epigenomic platform featuring a proprietary database of more than 5,000 epigenomes, designed to accelerate innovation and R&D.
Epigenomic Intelligence for Supporting Cosmetic Claims
We generate robust epigenomic evidence to demonstrate the efficacy of active ingredients and formulations, providing a solid scientific basis for your product claims.
Health Intelligence and Longevity
We develop customized solutions for healthcare providers, insurance companies, and longevity programs—estimating the risk of future chronic diseases based on epigenetic signatures.
Let's build a project together
Tell us about your company’s challenge, and we’ll design a customized epigenomic solution.